These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27523643)

  • 21. Retraction notice to "Design, synthesis, structure-activity relationship and kinase inhibitory activity of substituted 3-methyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ones" [Bioorg. Med. Chem. Lett. 26 (2016) 3093-3097].
    Lamie PF
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4220. PubMed ID: 28826507
    [No Abstract]   [Full Text] [Related]  

  • 22. Retraction notice to "Preclinical metabolism of LB42908, a novel farnesyl transferase inhibitor, and its effects on the cytochrome P450 isozyme activities" [Bioorg. Med. Chem. Lett. 22(9) (2012) 3067-3071].
    Chang M; Lee SH; Kim HJ; Koh JS; Kim A
    Bioorg Med Chem Lett; 2024 May; 104():129734. PubMed ID: 38604924
    [No Abstract]   [Full Text] [Related]  

  • 23. Corrigendum to "Design, synthesis, and biological evaluation of a new class of histone acetyltransferase p300 inhibitors" [Eur. J. Med. Chem. 180 (2019) 171e190].
    Liu R; Zhang Z; Yang H; Zhou K; Geng M; Zhou W; Zhang M; Huang X; Li Y
    Eur J Med Chem; 2020 Jan; 186():111899. PubMed ID: 31787358
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum to "Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors" [Eur. J. Med. Chem. 197 (2020) 112308].
    Shuai W; Li X; Li W; Xu F; Lu L; Yao H; Yang L; Zhu H; Xu S; Zhu Z; Xu J
    Eur J Med Chem; 2020 Aug; 200():112464. PubMed ID: 32512484
    [No Abstract]   [Full Text] [Related]  

  • 25. Retraction notice to “Memantine enhances the inhibitory effects of naltrexone on ethanol consumption” [Eur.J.Pharmacol.584(2–3) (2008)352–356].
    Eur J Pharmacol; 2015 Aug; 761():424. PubMed ID: 26478934
    [No Abstract]   [Full Text] [Related]  

  • 26. Corrigendum to "From irreversible to reversible covalent inhibitors: Harnessing the andrographolide scaffold for anti-inflammatory action" [Eur. J. Med. Chem. 204 (2020) 112481].
    Tran QTN; Tan DWS; Wong WSF; Chai CLL
    Eur J Med Chem; 2021 Jan; 209():112943. PubMed ID: 33097302
    [No Abstract]   [Full Text] [Related]  

  • 27. Retraction notice to "Introduction of antisense oligonucleotides to Heat Shock Protein 47 prevents pulmonary fibrosis in lipopolysaccharide-induced pneumopathy of the rat" [Eur. J. Pharmacol. 564/1-3 (2007) 174-180].
    Hagiwara S; Iwasaka H; Matsumoto S; Noguchi T
    Eur J Pharmacol; 2016 Dec; 792():80. PubMed ID: 27916230
    [No Abstract]   [Full Text] [Related]  

  • 28. Corrigendum to <' Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors' [Eur. J. Med. Chem. 211 (2021), 113109].
    Alvarez RM; García AB; Riesco-Fagundo C; Martín JI; Varela C; Rodríguez Hergueta A; González Cantalapiedra E; Oyarzabal J; Di Geronimo B; Lorenzo M; Albarrán MI; Cebriá A; Cebrián D; Martínez-González S; Blanco-Aparicio C; Pastor J
    Eur J Med Chem; 2021 Nov; 224():113703. PubMed ID: 34284231
    [No Abstract]   [Full Text] [Related]  

  • 29. Retraction notice to “Prostate cancer screening in the Tyrol, Austria: experience and results” [Eur J Cancer 36 (2000) 1322–1335].
    Eur J Cancer; 2012 Jan; 48(2):286. PubMed ID: 22308570
    [No Abstract]   [Full Text] [Related]  

  • 30. Retraction notice to "Carboxylated calixarenes bind strongly to CD69 and protect CD69(+) killer cells from suicidal cell death induced by tumor cell surface ligands" [Bioorg. Med. Chem. 18 (4) (2010) 1434–1440].
    Bioorg Med Chem; 2014 Jun; 22(12):3227. PubMed ID: 24955474
    [No Abstract]   [Full Text] [Related]  

  • 31. Corrigendum to "Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer" [Eur. J. Med. Chem. 163 (2019) 787-803].
    Wang C; Wang B; Hou S; Xue L; Kang Z; Du J; Li Y; Liu X; Wang Q; Zhang C
    Eur J Med Chem; 2020 Jan; 186():111907. PubMed ID: 31791642
    [No Abstract]   [Full Text] [Related]  

  • 32. Corrigendum to"Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo"[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086].
    Ojha R; Nepali K; Chen CH; Chuang KH; Wu TY; Lin TE; Hsu KC; Chao MW; Lai MJ; Lin MH; Huang HL; Chang CD; Pan SL; Chen MC; Liou JP
    Eur J Med Chem; 2020 Sep; 201():112404. PubMed ID: 32526554
    [No Abstract]   [Full Text] [Related]  

  • 33. Retraction notice to “Expression of a truncated Hmga1b gene induces gigantism, lipomatosis and B-cell lymphomas in mice” [Eur J Cancer 47 (2011) 470–478].
    Eur J Cancer; 2015 Apr; 51(6):789. PubMed ID: 25977969
    [No Abstract]   [Full Text] [Related]  

  • 34. Retraction notice to “PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell lines” [Eur. J. Pharmacol. 714(1–3) (2013) 379–387].
    Eur J Pharmacol; 2014 Apr; 728():190. PubMed ID: 24795989
    [No Abstract]   [Full Text] [Related]  

  • 35. Retraction notice to "Bioartificial grafts for transmural myocardial restoration: a new cardiovascular tissue culture concept" [Eur. J. Cardiothorac. Surg. 24 (2003) 906–911].
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1555. PubMed ID: 22191098
    [No Abstract]   [Full Text] [Related]  

  • 36. Corrigendum to "Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitors" [Eur. J. Med. Chem. 181 (2019) 111562].
    Gaines T; Garcia F; Virani S; Liang Z; Yoon Y; Oum YH; Shim H; Mooring SR
    Eur J Med Chem; 2023 Dec; 261():115753. PubMed ID: 37634992
    [No Abstract]   [Full Text] [Related]  

  • 37. Corrigendum to "N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression"[Eur. J. Med. Chem. 2020 Jan 1;185:111725].
    Mehndiratta S; Lin MH; Wu YW; Chen CH; Wu TY; Chuang KH; Chao MW; Chen YY; Pan SL; Chen MC; Liou JP
    Eur J Med Chem; 2020 Aug; 199():112406. PubMed ID: 32408215
    [No Abstract]   [Full Text] [Related]  

  • 38. Retraction notice to "Synthesis and bioevaluation of aryl-guanidino polyamine conjugates targeting the polyamine transporter" [Bioorg. Med. Chem. Lett. 20 (2010) 6421-6425].
    Wang J; Chen Z; Xie S; Zhao J; Wang C
    Bioorg Med Chem Lett; 2021 Sep; 47():128251. PubMed ID: 34256984
    [No Abstract]   [Full Text] [Related]  

  • 39. Retraction notice to "The use of super-selective mesenteric embolisation as a first-line management of acute lower gastrointestinal bleeding" [Ann. Med. Surg. 17 (2017) 27-32].
    Soh B; Chan S
    Ann Med Surg (Lond); 2018 Feb; 26():43. PubMed ID: 30967941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corrigendum to "Synthesis and cytotoxic activity of novel A-ring cleaved ursolic acid derivatives in human non-small cell lung cancer cells" [Eur. J. Med. Chem. 123 (2016) 317-331].
    Mendes VIS; Bartholomeusz GA; Ayres M; Gandhi V; Salvador JAR
    Eur J Med Chem; 2016 Nov; 124():1004-1005. PubMed ID: 27783971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.